<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on European Union</title><link href="http://biotechresearchinfo.com/topic/european-union" rel="alternate"></link><id>http://biotechresearchinfo.com/topic/european-union</id><updated>2011-10-04T19:30:55Z</updated><entry><title>Petition demands US label genetically engineered food</title><link href="http://biotechresearchinfo.com/genetic-engineering/petition-demands-label-genetically-engineered-food-4840122a" rel="alternate"></link><updated>2011-10-04T19:30:55Z</updated><author><name>AFP American Edition</name></author><id>tag:biotechresearchinfo.com,2011-10-04:/genetic-engineering/petition-demands-label-genetically-engineered-food-4840122a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Supporters and producers of organic foods petitioned the US government Tuesday for mandatory labeling of genetically engineered foods, and encouraged consumers to go online and join the cause.&lt;/p&gt;&lt;p&gt;The 21 petitioners want the &lt;span&gt;&lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt;&lt;/span&gt; (FDA) to use the full power of the law to ensure that consumers know when they are buying food made with genetically modified ingredien...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Biotechnology Sector"></category><category term="United States"></category><category term="The White House"></category><category term="European Union"></category><category term="Washington, DC"></category><category term="China"></category><category term="Philadelphia"></category><category term="Japan"></category><category term="Europe"></category><category term="Australia"></category><category term="Food and Drug Administration"></category><category term="Belgium"></category><category term="New Zealand"></category><category term="Asia"></category><category term="Western Europe"></category><category term="Russia"></category><category term="East Asia"></category><category term="Oceania"></category><category term="Brussels"></category><category term="Environmental Working Group"></category><category term="Monsanto Company"></category><category term="Center for Food Safety"></category><category term="European Court of Justice"></category><category term="Organic Trade Association"></category><category term="Ken Cook"></category><category term="Nonprofits and NGOs"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category></entry><entry><title>EU opens anti-trust probe into stay-awake drug deal</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-opens-antitrust-probe-stayawake-drug-deal-4773793a" rel="alternate"></link><updated>2011-04-28T13:30:30Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2011-04-28:/pharmaceuticals-sector/eu-opens-antitrust-probe-stayawake-drug-deal-4773793a/</id><summary type="html">&lt;div&gt;&lt;p&gt;European antitrust authorities announced on Thursday the opening of a formal antitrust probe into US drugs company &lt;a title="Cephalon Inc." href="/topic/Cephalon+Inc." &gt;Cephalon&lt;/a&gt; and &lt;a title="Israel" href="/topic/Israel" &gt;Israel&lt;/a&gt;-based generic drugs firm Teva over stay-awake drug &lt;a title="Modafinil" href="/topic/Modafinil" &gt;Modafinil&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The controversial anti-tiredness drug, marketed under the brand-name &lt;span id="provigil" class="inform"&gt;&lt;a title="Provigil" href="/topic/...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Israel"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Middle East"></category><category term="Cephalon Inc."></category><category term="Western Europe"></category><category term="Provigil"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Modafinil"></category></entry><entry><title>GlaxoSmithKline reports profits rise</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/glaxosmithkline-reports-profits-rise-4773192a" rel="alternate"></link><updated>2011-04-27T11:30:25Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2011-04-27:/pharmaceuticals-sector/glaxosmithkline-reports-profits-rise-4773192a/</id><summary type="html">&lt;div&gt;&lt;p&gt;British drugmaker &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;GlaxoSmithKline&lt;/a&gt; said on Wednesday that net profit rose 14 percent to &amp;#163;1.525 billion (1.72 billion euros, $2.5 billion) in the first quarter, despite a slump in product sales.&lt;/p&gt;&lt;p&gt;Savings from a major cost-cutting programme and asset disposals helped to offset a 10-percent drop in sales to &amp;#163;6.585 billion in the three months to March 31, compared with the first quarter of 2010, GSK said in a...</summary><category term="Financial Markets"></category><category term="European Markets"></category><category term="British Markets"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="GlaxoSmithKline plc"></category><category term="Avandia"></category><category term="Avandamet"></category><category term="Valtrex"></category><category term="Andrew Witty"></category><category term="World Markets"></category><category term="FTSE 100 Index"></category></entry><entry><title>Bid to ban cloned foods in Europe collapses</title><link href="http://biotechresearchinfo.com/cloning/bid-ban-cloned-foods-europe-collapses-4760648a" rel="alternate"></link><updated>2011-03-29T08:30:18Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2011-03-29:/cloning/bid-ban-cloned-foods-europe-collapses-4760648a/</id><summary type="html">&lt;div&gt;&lt;p&gt;An effort to ban cloned foods from supermarket shelves in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt; collapsed on Tuesday after &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; states and the parliament failed to agree a law to control the industry.&lt;/p&gt;&lt;p&gt;Although both sides agree on banning meat directly derived from cloned animals, government officials and Euro MPs clashed over regulating foods produced from the offspring of clones.&lt;/p&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Hungary" ...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Brazil"></category><category term="South America"></category><category term="Western Europe"></category><category term="Argentina"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Genetic Engineering"></category></entry><entry><title>EU talks on food from cloned animals collapse</title><link href="http://biotechresearchinfo.com/cloning/eu-talks-food-cloned-animals-collapse-4760532a" rel="alternate"></link><updated>2011-03-29T04:32:07Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2011-03-29:/cloning/eu-talks-food-cloned-animals-collapse-4760532a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - Talks within the &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; broke down on Tuesday over how to deal with food from cloned animals, sending EU proposals on the sale of new types of foods back to the drawing board after three years of debate.&lt;/p&gt;&lt;p&gt;Following all-night negotiations in Brussels, EU lawm...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Brussels"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category><category term="Consumer Non-Cyclicals"></category></entry><entry><title>Offspring of clones in food chain leaves EU in bind</title><link href="http://biotechresearchinfo.com/cloning/offspring-clones-food-chain-leaves-eu-bind-4755592a" rel="alternate"></link><updated>2011-03-17T16:30:32Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2011-03-17:/cloning/offspring-clones-food-chain-leaves-eu-bind-4755592a/</id><summary type="html">&lt;div&gt;&lt;p&gt;A new law regulating access for the first time for offspring of cloned animals to meat markets in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt; is heading for the dustbin, the &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt;'s current chair said Thursday.&lt;/p&gt;&lt;p&gt;A string of "Frankenfood" scares following the emergence of "non-traceable offspring" in the food chain in &lt;span&gt;&lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;&lt;/span&gt; and elsewhe...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Meat"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category></entry><entry><title>EU wrestles with issue of food from cloned animals</title><link href="http://biotechresearchinfo.com/cloning/eu-wrestles-issue-food-cloned-animals-4755494a" rel="alternate"></link><updated>2011-03-17T14:00:27Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2011-03-17:/cloning/eu-wrestles-issue-food-cloned-animals-4755494a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; governments and lawmakers remained deadlocked on how to regulate the production and sale of food from cloned animals, following all-night talks in Brussels that ended on Thursday morning.&lt;/p&gt;&lt;p&gt;EU sources said the remaining sticking point was a demand by l...</summary><category term="Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Animal Production"></category><category term="Dairy Farming"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Scotland"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category></entry><entry><title>Are patent deals slowing cheaper drugs?</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/patent-deals-slowing-cheaper-drugs-4730542a" rel="alternate"></link><updated>2011-01-17T13:00:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2011-01-17:/pharmaceuticals-sector/patent-deals-slowing-cheaper-drugs-4730542a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - The &lt;span&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;&lt;/span&gt; regulator said on Monday it was pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper drugs coming to market.&lt;/p&gt;&lt;p&gt;The move is the latest in a series of EU crackd...</summary><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Switzerland"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="Joaquin Almunia"></category></entry><entry><title>UK watchdog adviser: Cloned cattle meat likely safe</title><link href="http://biotechresearchinfo.com/cloning/uk-watchdog-adviser-cloned-cattle-meat-safe-4389705a" rel="alternate"></link><updated>2010-11-26T07:00:16Z</updated><author><name>Reuters US Online Report Science News</name></author><id>tag:biotechresearchinfo.com,2010-11-26:/cloning/uk-watchdog-adviser-cloned-cattle-meat-safe-4389705a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;LONDON&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - Meat and milk from cloned cattle show no difference in composition from that of traditionally bred cows and so are unlikely to pose a food safety risk, an advisory committee to &lt;span&gt;&lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;&lt;/span&gt;'s food safety regulator said.&lt;/p&gt;&lt;p&gt;The &lt;span&gt;Advisory &lt;a title="Committee on Novel" href="/topic/Committee+on+Novel" &gt;Comm...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="British Politics"></category><category term="EU Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food Safety"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Western Europe"></category><category term="University of London"></category><category term="Reuters Group plc"></category><category term="Soil Association"></category><category term="Food Standards Agency"></category><category term="Genetic Engineering"></category><category term="Brendan Curran"></category><category term="Dairy and Eggs"></category></entry><entry><title>No cloned steaks on EU plates</title><link href="http://biotechresearchinfo.com/cloning/cloned-steaks-eu-plates-2154831a" rel="alternate"></link><updated>2010-10-19T09:31:04Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-10-19:/cloning/cloned-steaks-eu-plates-2154831a/</id><summary type="html">&lt;div&gt;&lt;p&gt;"Cloning for food is not required" across the &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;, European health commissioner &lt;span&gt;John Dalli&lt;/span&gt; told a news conference. "There's no need for it."&lt;/p&gt;&lt;p&gt;The plan is to be published as legislative proposals next year but will need to be approved by EU governments and lawmakers.&lt;/p&gt;&lt;p&gt;It would enable cloning for uses other than food, such as research, conservation of endangered species or use of animals for the production of...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Western Europe"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category></entry><entry><title>EU exec proposes ban on animal cloning for food</title><link href="http://biotechresearchinfo.com/cloning/eu-exec-proposes-ban-animal-cloning-food-2153256a" rel="alternate"></link><updated>2010-10-22T13:29:37Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/cloning/eu-exec-proposes-ban-animal-cloning-food-2153256a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;span&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt;&lt;/span&gt; (&lt;span&gt;&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;&lt;/span&gt;) - The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; announced plans on Tuesday to temporarily ban the use of animal cloning for food production, while allowing imports of food derived from the offspring of clones from the &lt;span&gt;&lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt;&lt;/spa...</summary><category term="Trade"></category><category term="Imports and Exports"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Brazil"></category><category term="South America"></category><category term="Western Europe"></category><category term="Scotland"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="European Parliament"></category><category term="Genetic Engineering"></category><category term="Imports"></category></entry><entry><title>Pfizer to Acquire FoldRx Pharmaceuticals</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/pfizer-acquire-foldrx-pharmaceuticals-1371933a" rel="alternate"></link><updated>2010-09-11T13:29:53Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-09-11:/pharmaceuticals-sector/pfizer-acquire-foldrx-pharmaceuticals-1371933a/</id><summary type="html">...</summary><category term="Private Equity"></category><category term="Venture Capital"></category><category term="Clinical Trials"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Respiratory Medicine"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New York"></category><category term="Goldman Sachs Group Inc."></category><category term="Food and Drug Administration"></category><category term="Jefferies Group Inc."></category><category term="Novartis AG"></category><category term="European Medicines Agency"></category><category term="The Scripps Research Institute"></category><category term="Pfizer Inc."></category><category term="Cambridge"></category><category term="PR Newswire Association LLC"></category><category term="Susan Lindquist"></category><category term="Alta Partners"></category><category term="Ropes &amp; Gray LLP"></category><category term="Morgenthaler LLP"></category><category term="Geno Germano"></category><category term="Jeffery Kelly"></category><category term="Richard Labaudiniere"></category><category term="FoldRX Pharmaceuticals Inc."></category><category term="HealthCare Ventures LLC"></category><category term="Novo Ventures"></category></entry><entry><title>Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion now available at ReportsandReports</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/commercial-insight-antihormonal-cancer-therapies-leading-brands-strive-minimize-generic-sales-erosion-reportsandreports-1191728a" rel="alternate"></link><updated>2010-09-09T20:08:21Z</updated><author><name>ArticlesBase</name></author><id>tag:biotechresearchinfo.com,2010-09-09:/pharmaceuticals-sector/commercial-insight-antihormonal-cancer-therapies-leading-brands-strive-minimize-generic-sales-erosion-reportsandreports-1191728a/</id><summary type="html">&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the antihormonal therapy cancer brands generated sales of about $7.0 billion in the seven major pharmaceutical markets in 2009.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Scope&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;* In-depth analysis of the current and futur...</summary><category term="Marketing"></category><category term="Sales Forecasting"></category><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Breast Cancer Treatment"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Medicare"></category><category term="Germany"></category><category term="Japan"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Spain"></category><category term="France"></category><category term="Asia"></category><category term="Women's Health"></category><category term="AstraZeneca Group"></category><category term="European Medicines Agency"></category><category term="Western Europe"></category><category term="East Asia"></category><category term="Datamonitor plc"></category><category term="Lupron"></category><category term="Southern Europe"></category><category term="Casodex"></category><category term="Arimidex"></category></entry><entry><title>Summary Box: Drugmakers post higher Q2 results</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/summary-box-drugmakers-post-higher-q2-results-999513a" rel="alternate"></link><updated>2010-07-22T15:15:24Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-07-22:/pharmaceuticals-sector/summary-box-drugmakers-post-higher-q2-results-999513a/</id><summary type="html">&lt;div id="subtitle"&gt;Summary Box: Drugmakers post higher Q2 results, despite health reform, &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; economic pressures&lt;/div&gt;&lt;div&gt;&lt;p&gt;HEALTHY SIGNS: Three of the Top 20 drugmakers &amp;#8212; &lt;a title="Bristol-Myers Squibb Company" href="/topic/Bristol-Myers+Squibb+Company" &gt;Bristol-Myers Squibb Co.&lt;/a&gt;, &lt;a title="F. Hoffman-La Roche Ltd." href="/topic/F.+Hoffman-La+Roche+Ltd." &gt;Roche Holding AG&lt;/a&gt; and &lt;a title="Eli Lilly and Company" href="/topic/...</summary><category term="EU Economy"></category><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Health Care Policy"></category><category term="Health Care Issues"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Eli Lilly and Company"></category><category term="Bristol-Myers Squibb Company"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Health Care Reform"></category></entry><entry><title>Cutting Drug Prices Can Hamper Development of New Medicines, Shows New Study By ESMT Competition Analysis</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/cutting-drug-prices-hamper-development-new-medicines-shows-new-study-esmt-competition-analysis-3515855a" rel="alternate"></link><updated>2010-11-02T12:39:25Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-11-02:/pharmaceuticals-sector/cutting-drug-prices-hamper-development-new-medicines-shows-new-study-esmt-competition-analysis-3515855a/</id><summary type="html">...</summary><category term="Clinical Trials"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Organisation for Economic Co-operation and Development"></category><category term="Berlin (Germany)"></category><category term="Hans Friederiszick"></category><category term="Farhad Dilmaghani"></category><category term="Kristin Dolgner"></category><category term="ESMT Competition Analysis ESMT European School of Management and Technology"></category></entry><entry><title>A.M. Vitals: A Genetic Test Pegging the Odds of Living Past 100</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/vitals-genetic-test-pegging-odds-living-1-3591989a" rel="alternate"></link><updated>2010-11-02T14:14:34Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:biotechresearchinfo.com,2010-11-02:/pharmaceuticals-sector/vitals-genetic-test-pegging-odds-living-1-3591989a/</id><summary type="html">...</summary><category term="Trials"></category><category term="Contagious and Infectious Diseases"></category><category term="Influenza"></category><category term="Medical Treatments and Procedures"></category><category term="Vaccines"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="The New York Times Company"></category><category term="Virginia"></category><category term="U.S. Department of Justice"></category><category term="European Commission"></category><category term="AstraZeneca Group"></category><category term="Boston University"></category><category term="The Associated Press"></category><category term="Prilosec"></category><category term="Losec"></category><category term="Swine Flu"></category><category term="Immunotherapy"></category></entry><entry><title>AstraZeneca loses generic drug case versus EU</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/astrazeneca-loses-generic-drug-case-eu-980044a" rel="alternate"></link><updated>2010-09-22T13:56:16Z</updated><author><name>Reuters US Online Report Business News</name></author><id>tag:biotechresearchinfo.com,2010-09-22:/pharmaceuticals-sector/astrazeneca-loses-generic-drug-case-eu-980044a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; court backed an EU antitrust decision against Anglo-Swedish drugmaker &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; Thursday, lending weight to a regulatory crackdown on firms blocking cheaper drugs coming to market.&lt;/p&gt;&lt;p&gt;Antitrust lawyers said th...</summary><category term="Stock Prices"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Norway"></category><category term="Denmark"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="Nordic Countries"></category><category term="Boehringer Ingelheim GmbH"></category><category term="Losec"></category><category term="Sarah Lindgreen"></category><category term="Ben Deighton"></category><category term="David Cowell"></category><category term="Nicola Dagg"></category></entry><entry><title>EU to allow nations to ban approved GM crops</title><link href="http://biotechresearchinfo.com/biotechnology/eu-nations-ban-approved-gm-crops-953736a" rel="alternate"></link><updated>2010-06-04T09:17:49Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-06-04:/biotechnology/eu-nations-ban-approved-gm-crops-953736a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Individual &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; nations will be free to ban genetically modified crops, even if they are deemed safe and approved, under rule changes being drawn up by &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt; to unblock the clearance process.&lt;/p&gt;&lt;p&gt;EU &lt;a title="John Dalli" href="/topic/John+Dalli" &gt;Health Commissioner John Dalli&lt;/a&gt;, in charge of the emotive dossier, will hand over plans to national capitals and the EU parliament ...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="Italy"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Central Europe"></category><category term="Brussels"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Friends of the Earth"></category><category term="Southern Europe"></category><category term="Marco Contiero"></category><category term="BASF SE"></category><category term="John Dalli"></category><category term="Genetically Modified Organisms"></category></entry><entry><title>Drugmakers lose fight over cheap UK medicines</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/drugmakers-lose-fight-cheap-uk-medicines-912047a" rel="alternate"></link><updated>2010-04-22T05:45:14Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:biotechresearchinfo.com,2010-04-22:/pharmaceuticals-sector/drugmakers-lose-fight-cheap-uk-medicines-912047a/</id><summary type="html">&lt;div&gt;&lt;p&gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Drug companies have lost a legal battle against schemes promoted by &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt;'s state health service that encourage doctors to prescribe cheaper medicines.&lt;/p&gt;&lt;p&gt;The &lt;a title="Association of the British Pharmaceutical Industry" href="/topic/Association+of+the+British+Pharmaceutical+Industry" &gt;Association of the British Pharmaceutical Industry&lt;/a&gt; ...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Social Policy"></category><category term="Public Health Policy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="European Court of Justice"></category><category term="Association of the British Pharmaceutical Industry"></category><category term="Isabel Manley"></category></entry><entry><title>France blasts GM crop approvals by EU agency</title><link href="http://biotechresearchinfo.com/biotechnology/france-blasts-gm-crop-approvals-eu-agency-864216a" rel="alternate"></link><updated>2010-10-22T10:14:43Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/france-blasts-gm-crop-approvals-eu-agency-864216a/</id><summary type="html">&lt;div&gt;&lt;p&gt;PARIS (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;'s food safety agency has used partial evidence to approve genetically modified crops, including a GM potato developed by &lt;a title="BASF SE" href="/topic/BASF+SE" &gt;BASF&lt;/a&gt;, and should overhaul its methods, a French environment minister said.&lt;/p&gt;&lt;p&gt;&lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt; has previously invoked environmental risks to suspend cult...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Organic Foods"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="French Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Food Safety"></category><category term="Crop Production"></category><category term="Chemicals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Monsanto Company"></category><category term="European Food Safety Agency"></category><category term="Environmental Issues and Protection"></category><category term="BASF SE"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Le Parisien"></category></entry><entry><title>'Battle' on GM foods can't be won: EU official</title><link href="http://biotechresearchinfo.com/biotechnology/battle-gm-foods-won-eu-official-862197a" rel="alternate"></link><updated>2010-03-03T13:18:52Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-03-03:/biotechnology/battle-gm-foods-won-eu-official-862197a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Parliament" href="/topic/European+Parliament" &gt;European Parliament&lt;/a&gt; President Jerzy Buzek said on Wednesday he was against genetically-modified foods but said they were an unavoidable part of the future.&lt;/p&gt;&lt;p&gt;Asked by students in &lt;a title="Sofia" href="/topic/Sofia" &gt;Sofia&lt;/a&gt; whether he was against GM foods, after the &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; approved their cultivation, he said: "I am, generally speaking, against because we do...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Organic Foods"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Bulgaria"></category><category term="The Balkans"></category><category term="Bangladesh"></category><category term="Sofia"></category><category term="European Parliament"></category></entry><entry><title>Fury as Brussels authorises GM potatoes</title><link href="http://biotechresearchinfo.com/biotechnology/fury-brussels-authorises-gm-potatoes-860933a" rel="alternate"></link><updated>2010-03-03T08:16:18Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-03-03:/biotechnology/fury-brussels-authorises-gm-potatoes-860933a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; on Tuesday approved the cultivation of genetically-modified potatoes, prompting an angry response from environmental campaign groups and two &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; member governments.&lt;/p&gt;&lt;p&gt;&lt;a title="Austria" href="/topic/Austria" &gt;Austria&lt;/a&gt; said it was planning an immediate ban on the potatoes' cultivation, while &lt;a title="Italy" href="/topic/Italy" &gt;It...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Fruits and Vegetables"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category><category term="Italy"></category><category term="Europe"></category><category term="European Commission"></category><category term="Austria"></category><category term="Central Europe"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Friends of the Earth"></category><category term="Southern Europe"></category><category term="Luca Zaia"></category><category term="Marco Contiero"></category><category term="BASF SE"></category><category term="Alois Stoeger"></category><category term="John Dalli"></category></entry><entry><title>XM02</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/xm02-3070989a" rel="alternate"></link><updated>2010-10-24T15:17:51Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/xm02-3070989a/</id><summary type="html">...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="North America"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Israel"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Middle East"></category><category term="European Medicines Agency"></category><category term="Copaxone"></category><category term="Neurontin"></category><category term="Lotrel"></category><category term="Neupogen"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Protonix"></category><category term="Blood Disorders"></category><category term="Eloxatin"></category><category term="Private Securities Litigation Reform Act"></category></entry><entry><title>Turns Out, Pfizer Was Also Questioned in EU On Generic Deals</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/turns-pfizer-questioned-eu-generic-deals-3082044a" rel="alternate"></link><updated>2010-10-24T15:31:07Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/turns-pfizer-questioned-eu-generic-deals-3082044a/</id><summary type="html">...</summary><category term="Consumer Protection"></category><category term="Jobs and Labor"></category><category term="Labor Unions"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="U.S. Federal Trade Commission"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Dow Jones &amp; Co. Inc."></category></entry><entry><title>EU probes Danish drug maker for generic drug delay</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-probes-danish-drug-maker-generic-drug-delay-807171a" rel="alternate"></link><updated>2010-04-16T07:50:53Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-probes-danish-drug-maker-generic-drug-delay-807171a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; says it suspects &lt;a title="Denmark" href="/topic/Denmark" &gt;Denmark&lt;/a&gt;'s &lt;a title="H. Lundbeck AS" href="/topic/H.+Lundbeck+AS" &gt;Lundbeck&lt;/a&gt; may have blocked launch of generic antidepressants&lt;/div&gt;&lt;div&gt;&lt;p&gt;European Union regulators said Thursday that they suspect Danish drug maker Lundbeck may have delayed the launch of a cheaper, generic version of its antidepressant drug in &lt;a title="Europe" href="/topic/Europe" ...</summary><category term="Monopolies"></category><category term="Crime"></category><category term="Corporate Crime"></category><category term="Antitrust Crime"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Mental Health"></category><category term="Mood Disorders"></category><category term="Depression"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Denmark"></category><category term="Europe"></category><category term="European Commission"></category><category term="Canada"></category><category term="Copenhagen"></category><category term="Celexa"></category><category term="Nordic Countries"></category><category term="Jan Olsen"></category><category term="Neelie Kroes"></category><category term="Jonathan Todd"></category><category term="H. Lundbeck AS"></category></entry><entry><title>French body says Monsanto maize needs more study</title><link href="http://biotechresearchinfo.com/biotechnology/french-body-monsanto-maize-study-789803a" rel="alternate"></link><updated>2010-04-16T08:11:21Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/biotechnology/french-body-monsanto-maize-study-789803a/</id><summary type="html">&lt;div&gt;&lt;p&gt;PARIS (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - More research is needed into &lt;a title="Monsanto Company" href="/topic/Monsanto+Company" &gt;Monsanto&lt;/a&gt;'s genetically modified maize MON 810, the only biotech crop commercially grown in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;, to assess its environmental impact, a French advisory body said.&lt;/p&gt;&lt;p&gt;The opinion given by biotech committee HCB, published on Tuesday, was requested by the French governm...</summary><category term="Technology"></category><category term="Biotechnology"></category><category term="Food Safety"></category><category term="European Union"></category><category term="Europe"></category><category term="France"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Monsanto Company"></category><category term="European Food Safety Authority"></category></entry><entry><title>EU raids drug makers in antitrust probe</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-raids-drug-makers-antitrust-probe-771833a" rel="alternate"></link><updated>2010-04-16T08:32:50Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-raids-drug-makers-antitrust-probe-771833a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; antitrust regulators said they made surprise raids on the offices of drug makers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals.&lt;/p&gt;&lt;p&gt;They did not name the companies and said the raids were a preliminary step in an antitrust investigation. If they find the firms guilty, they can fine them up to 10 percent ...</summary><category term="Monopolies"></category><category term="Crime"></category><category term="Corporate Crime"></category><category term="Antitrust Crime"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="France"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category><category term="Neelie Kroes"></category><category term="Servier Laboratories SA"></category><category term="Niche Generics Ltd."></category></entry><entry><title>EU Raids Drug Makers in Antitrust Probe</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-raids-drug-makers-antitrust-probe-3064094a" rel="alternate"></link><updated>2010-10-24T10:10:25Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/eu-raids-drug-makers-antitrust-probe-3064094a/</id><summary type="html">...</summary><category term="Monopolies"></category><category term="Crime"></category><category term="Corporate Crime"></category><category term="Antitrust Crime"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="France"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category><category term="Neelie Kroes"></category><category term="Servier Laboratories SA"></category><category term="Niche Generics Ltd."></category></entry><entry><title>Teva Announces the Submission of a Biologics License Application (BLA) for XM02 for the Treatment of Chemotherapy-Induced Neutropenia</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/teva-announces-submission-biologics-license-application-bla-xm02-treatment-chemotherapyinduced-neutropenia-3063920a" rel="alternate"></link><updated>2010-10-24T10:10:17Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/teva-announces-submission-biologics-license-application-bla-xm02-treatment-chemotherapyinduced-neutropenia-3063920a/</id><summary type="html">...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Cancer"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="North America"></category><category term="U.S. Securities and Exchange Commission"></category><category term="Israel"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Middle East"></category><category term="European Medicines Agency"></category><category term="Copaxone"></category><category term="Neurontin"></category><category term="Lotrel"></category><category term="Neupogen"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Protonix"></category><category term="Blood Disorders"></category><category term="William Marth"></category><category term="Eloxatin"></category><category term="Chemotherapy"></category><category term="Private Securities Litigation Reform Act"></category></entry><entry><title>Chiesi Is Top Italian Pharmaceutical Group for Investment In Research</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/chiesi-top-italian-pharmaceutical-group-investment-research-3063715a" rel="alternate"></link><updated>2010-10-24T10:10:08Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/chiesi-top-italian-pharmaceutical-group-investment-research-3063715a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Research and Development"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Finmeccanica SpA"></category><category term="European Commission"></category><category term="Switzerland"></category><category term="Brazil"></category><category term="France"></category><category term="South America"></category><category term="Rockville"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Parma"></category><category term="Fiat SpA"></category><category term="Pirelli &amp; C. SpA"></category><category term="Telecom Italia SpA"></category><category term="Boehringer Ingelheim GmbH"></category><category term="Southern Europe"></category><category term="Curosurf"></category><category term="Joint Research Centre"></category><category term="Paris (France)"></category><category term="Alberto Chiesi"></category><category term="Cristina Depaoli"></category><category term="Santana de Parnaiba"></category><category term="Chiesi Farmaceutici SpA"></category></entry><entry><title>EU approves Merck takeover of Schering-Plough</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-approves-merck-takeover-scheringplough-714854a" rel="alternate"></link><updated>2010-04-16T09:41:21Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-approves-merck-takeover-scheringplough-714854a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; approved Merck &amp;amp;amp;amp; Co.'s proposed takeover of &lt;a title="Schering-Plough Corporation" href="/topic/Schering-Plough+Corporation" &gt;Schering-Plough&lt;/a&gt;, which would create the second-biggest global producer of prescription medicines.&lt;/p&gt;&lt;p&gt;The EU's antitrust authorities said in a statement Friday that the "transaction would not significantly impede effective competition" in &lt;a title="Europe" href="/topic...</summary><category term="Company Activities and Information"></category><category term="Partnerships"></category><category term="Cholesterol"></category><category term="Animal Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="Europe"></category><category term="European Commission"></category><category term="U.S. Federal Trade Commission"></category><category term="Schering-Plough Corporation"></category><category term="Vytorin"></category><category term="Zetia"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Schering AG"></category><category term="Dr. Scholl's Foot Care Products"></category><category term="Coppertone Sun Care Products"></category><category term="Richard Clark"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>EU approves Merck, Schering-Plough tie-up</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-approves-merck-scheringplough-tieup-714895a" rel="alternate"></link><updated>2010-04-16T09:41:19Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-approves-merck-scheringplough-tieup-714895a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; approves proposed Merck, &lt;a title="Schering-Plough Corporation" href="/topic/Schering-Plough+Corporation" &gt;Schering-Plough&lt;/a&gt; tie-up, no competition worries in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;The European Union on Friday approved the proposed tie-up of &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; drug makers Merck &amp;amp;amp;amp; Co. and Schering-Plough Corp. which w...</summary><category term="Company Activities and Information"></category><category term="Partnerships"></category><category term="Cholesterol"></category><category term="Animal Diseases"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="Europe"></category><category term="European Commission"></category><category term="U.S. Federal Trade Commission"></category><category term="Schering-Plough Corporation"></category><category term="Vytorin"></category><category term="Zetia"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Schering AG"></category><category term="Dr. Scholl's Foot Care Products"></category><category term="Coppertone Sun Care Products"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>EU favours big drug firms over people in need: NGOs</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-favours-big-drug-firms-people-ngos-711145a" rel="alternate"></link><updated>2010-04-16T09:44:39Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-favours-big-drug-firms-people-ngos-711145a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; is putting the interests of big drug companies ahead of those of millions of people without access to essential medicines, two non-governmental organisations said Tuesday.&lt;/p&gt;&lt;p&gt;The EU's executive arm, the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt;, was also accused of acting against the spirit of world trade rules, in a new report by &lt;a title="Oxfam International...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Economic Issues"></category><category term="Economic Development"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Oxfam International"></category><category term="Nonprofits and NGOs"></category><category term="Health Action International"></category></entry><entry><title>EU farm ministers refuse to okay new GM maize strains</title><link href="http://biotechresearchinfo.com/biotechnology/eu-farm-ministers-refuse-new-gm-maize-strains-709975a" rel="alternate"></link><updated>2010-04-16T09:45:46Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/biotechnology/eu-farm-ministers-refuse-new-gm-maize-strains-709975a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; farm ministers refused to give their seal of approval on Monday to plans to allow the import of genetically-modified maize from US growers, diplomats said.&lt;/p&gt;&lt;p&gt;During a meeting of European Union agriculture ministers in &lt;a title="Luxembourg" href="/topic/Luxembourg" &gt;Luxembourg&lt;/a&gt; dominated by crisis in the dairy sector, nations were unable to agree on proposals to greenlight the latest batch of so-called 'Fran...</summary><category term="Technology"></category><category term="Biotechnology"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="Belgium"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Brussels"></category><category term="Monsanto Company"></category><category term="Luxembourg"></category><category term="Mariann Fischer Boel"></category></entry><entry><title>EU and Greenpeace row over safety of GM food</title><link href="http://biotechresearchinfo.com/biotechnology/eu-greenpeace-row-safety-gm-food-705614a" rel="alternate"></link><updated>2010-04-16T09:49:37Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/biotechnology/eu-greenpeace-row-safety-gm-food-705614a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Commission" href="/topic/European+Commission" &gt;EU Commission&lt;/a&gt; stressed Thursday that health and environmental factors were foremost in approving genetically modified foodstuffs, while protesting farmers and environmentalists called for an outright ban.&lt;/p&gt;&lt;p&gt;"GMOs (genetically modified organisms) are one of the most sensitive dossiers on my desk," &lt;a title="Androulla Vassiliou" href="/topic/Androulla+Vassiliou" &gt;EU Health Commissioner Androulla Vassiliou&lt;/a&gt; sai...</summary><category term="Food and Cooking"></category><category term="Foods"></category><category term="Organic Foods"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Crop Production"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="Spain"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Brussels"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Luxembourg"></category><category term="European Food Safety Authority"></category><category term="Androulla Vassiliou"></category><category term="Marco Contiero"></category><category term="Eduardo Campayo Garcia"></category></entry><entry><title>Concern over UK firms ignorance of REACH</title><link href="http://biotechresearchinfo.com/biotechnology/concern-uk-firms-ignorance-reach-2763262a" rel="alternate"></link><updated>2010-10-22T12:23:07Z</updated><author><name>The Encyclopedia Britannica</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/concern-uk-firms-ignorance-reach-2763262a/</id><summary type="html">...</summary><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Greenpeace International"></category><category term="CropLife International"></category><category term="European Chemicals Agency"></category><category term="Howard Minigh"></category><category term="NEWS CropLife International"></category></entry><entry><title>Sanofi says doors 'wide open' to EU drugs probe</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/sanofi-doors-wide-open-eu-drugs-probe-2528741a" rel="alternate"></link><updated>2010-10-22T07:47:07Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/pharmaceuticals-sector/sanofi-doors-wide-open-eu-drugs-probe-2528741a/</id><summary type="html">...</summary><category term="Antitrust Law"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category><category term="Teva Pharmaceutical Industries Ltd."></category><category term="Ranbaxy Pharmaceuticals Inc."></category><category term="Neelie Kroes"></category><category term="Chris Viehbacher"></category></entry><entry><title>EU raids drug makers on suspected antitrust abuse</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-raids-drug-makers-suspected-antitrust-abuse-696470a" rel="alternate"></link><updated>2010-04-16T09:56:55Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-raids-drug-makers-suspected-antitrust-abuse-696470a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Drug makers &lt;a title="Sanofi-Aventis SA" href="/topic/Sanofi-Aventis+SA" &gt;Sanofi-Aventis SA&lt;/a&gt;, &lt;a title="Novartis AG" href="/topic/Novartis+AG" &gt;Novartis AG&lt;/a&gt; and &lt;a title="Ratiopharm GmbH" href="/topic/Ratiopharm+GmbH" &gt;Ratiopharm International GmbH&lt;/a&gt; said Wednesday that &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; regulators had carried out surprise raids at their French offices as part of an antitrust probe.&lt;/p&gt;&lt;p&gt;The &lt;a title="European Commission" href="/topic...</summary><category term="Monopolies"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Switzerland"></category><category term="France"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category><category term="Neelie Kroes"></category><category term="Jean-Marc Podvin"></category><category term="Eric Althoff"></category><category term="Servier Laboratories SA"></category><category term="Niche Generics Ltd."></category></entry><entry><title>EU says investigators raid pharma giants</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-investigators-raid-pharma-giants-695424a" rel="alternate"></link><updated>2010-04-16T09:57:44Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-investigators-raid-pharma-giants-695424a/</id><summary type="html">&lt;div&gt;&lt;p&gt; Investigators raided at least two European pharmaceutical giants on Tuesday over suspected competition violations, the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; said.&lt;/p&gt;&lt;p&gt;The commission "can confirm that on October 6 commission officials started surprise inspections at the premises of certain companies active in the pharmaceutical industry," a statement said.&lt;/p&gt;&lt;p&gt;&lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt;'s &lt;a title="Sanofi-Ave...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Western Europe"></category><category term="Bayer AG"></category><category term="Sanofi-Aventis SA"></category><category term="Ratiopharm GmbH"></category><category term="Solvay SA"></category><category term="Servier Laboratories SA"></category></entry><entry><title>Public-Private Partnerships: A Recipe For Success?</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/publicprivate-partnerships-recipe-success-3363210a" rel="alternate"></link><updated>2010-10-26T23:20:32Z</updated><author><name>Science</name></author><id>tag:biotechresearchinfo.com,2010-10-26:/pharmaceuticals-sector/publicprivate-partnerships-recipe-success-3363210a/</id><summary type="html">...</summary><category term="Medical Treatments and Procedures"></category><category term="Pain Management"></category><category term="Sciences"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Italy"></category><category term="Europe"></category><category term="Barcelona"></category><category term="Spain"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="Switzerland"></category><category term="France"></category><category term="Madrid"></category><category term="Eli Lilly and Company"></category><category term="Critical Path Inc."></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Munich"></category><category term="Rolls-Royce plc"></category><category term="Chichester"></category><category term="Dortmund"></category><category term="Silvio Berlusconi"></category><category term="Max Planck Society"></category><category term="Max Planck"></category><category term="Southern Europe"></category><category term="England"></category><category term="Euroscience"></category><category term="Snecma SA"></category><category term="MTU Aero Engines GmbH"></category><category term="London (England)"></category><category term="Berlin (Germany)"></category><category term="Institute for Research in Biomedicine"></category><category term="AAAS/Science Business Office"></category><category term="Gunjan Sinha"></category><category term="Nanoelectronics Technologies"></category><category term="Eric Dautriat"></category><category term="Joan Guinovart"></category><category term="Jacky Vonderscher"></category><category term="Peter Tindemans"></category><category term="Benedikt Wolbeck"></category><category term="National Strategic Consortiums for Technological Research"></category><category term="Catharine Ray"></category><category term="Frieder Meyer-Krahmer"></category><category term="Inventive Capital Advisor LLP"></category></entry><entry><title>EU rejects more U.S. soy with GM corn traces</title><link href="http://biotechresearchinfo.com/biotechnology/eu-rejects-soy-gm-corn-traces-674619a" rel="alternate"></link><updated>2010-10-22T13:01:48Z</updated><author><name>Reuters Environmental Online Report</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/eu-rejects-soy-gm-corn-traces-674619a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Amsterdam" href="/topic/Amsterdam" &gt;AMSTERDAM&lt;/a&gt;/&lt;a title="Brussels" href="/topic/Brussels" &gt;BRUSSELS&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Spanish authorities detected traces of unauthorized forms of genetically modified (GM) corn in U.S. soy shipments on August 25 and blocked the imports, a &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; spokeswoman said on Friday.&lt;/p&gt;&lt;p&gt;Traces of corn vari...</summary><category term="Trade"></category><category term="Imports and Exports"></category><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Agriculture Policy"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="United States"></category><category term="European Union"></category><category term="Washington, DC"></category><category term="Germany"></category><category term="Europe"></category><category term="Spain"></category><category term="European Commission"></category><category term="Netherlands"></category><category term="Belgium"></category><category term="Madrid"></category><category term="Amsterdam"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Brussels"></category><category term="Monsanto Company"></category><category term="Mariann Fischer Boel"></category><category term="Martin Roberts"></category><category term="Spanish Agriculture Ministry"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Imports"></category></entry><entry><title>GM crop trials start again in Britain in 'secret': report</title><link href="http://biotechresearchinfo.com/biotechnology/gm-crop-trials-start-britain-secret-report-608591a" rel="alternate"></link><updated>2010-04-16T11:08:57Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/biotechnology/gm-crop-trials-start-britain-secret-report-608591a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Genetically modified crops are being grown in &lt;a title="United Kingdom" href="/topic/United+Kingdom" &gt;Britain&lt;/a&gt; for the first time in 12 months after controversial trials were resumed without alerting the public, a newspaper reported Monday.&lt;/p&gt;&lt;p&gt;Cultivation of a field of potatoes designed to be resistant to pests was abandoned more than a year ago when environmental protesters ripped up the crop, the &lt;a title="Telegraph Group Ltd." href="/topic/Telegraph+Group+Ltd." &gt;Daily Telegraph&lt;...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category><category term="North America"></category><category term="China"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="France"></category><category term="Asia"></category><category term="South America"></category><category term="Western Europe"></category><category term="East Asia"></category><category term="Telegraph Group Ltd."></category><category term="Northern England"></category><category term="University of Leeds"></category></entry><entry><title>EU warns of antitrust probes into drug makers</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-warns-antitrust-probes-drug-makers-586513a" rel="alternate"></link><updated>2010-06-11T20:18:15Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-06-11:/pharmaceuticals-sector/eu-warns-antitrust-probes-drug-makers-586513a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; warned Wednesday of a wave of antitrust investigations into major drugmakers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire.&lt;/p&gt;&lt;p&gt;"Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets," &lt;a title="Neelie Kroes" href="/topic/Neelie+Kroes" &gt;EU Competition Commissioner Neelie Kroes&lt;/a&gt; sai...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="Trenton"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="The Associated Press"></category><category term="Neelie Kroes"></category><category term="Linda Johnson"></category><category term="Sandoz International GmbH"></category><category term="Stephen Rea"></category><category term="Losec"></category><category term="Servier Laboratories SA"></category><category term="Niche Generics Ltd."></category><category term="Oliver Stohlmann"></category><category term="London (England)"></category></entry><entry><title>EU probes pharma industry over generic medicine concerns</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-probes-pharma-industry-generic-medicine-concerns-586882a" rel="alternate"></link><updated>2010-04-16T11:26:39Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-probes-pharma-industry-generic-medicine-concerns-586882a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt;'s competition regulator launched a probe into the pharmaceutical sector Wednesday over concerns that cheap generic medicines are not reaching patients in need.&lt;/p&gt;&lt;p&gt;The move came after a sector-wide report showed that the number of new drugs reaching the market annually had dropped by over a third since 2000 and that people are being deprived of innovative, affordable and safe medicine.&lt;/p&gt;&lt;p&gt;The competition ...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Neelie Kroes"></category><category term="Monique Goyens"></category><category term="European Consumers' Organisation"></category><category term="Servier Laboratories SA"></category><category term="European Federation of Pharmaceutical Industries"></category><category term="European Generic Medicines Association"></category></entry><entry><title>Delaying Generic Drugs Costs Patients &amp; Taxpayers, EU Says</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/delaying-generic-drugs-costs-patients-taxpayers-eu-3058337a" rel="alternate"></link><updated>2010-10-24T09:57:10Z</updated><author><name>Wall Street Journal Health Blog</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/delaying-generic-drugs-costs-patients-taxpayers-eu-3058337a/</id><summary type="html">...</summary><category term="Crime"></category><category term="Corporate Crime"></category><category term="Antitrust Crime"></category><category term="Antitrust Law"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="The New York Times Company"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Sanofi-Aventis SA"></category><category term="Dow Jones &amp; Co. Inc."></category><category term="Neelie Kroes"></category><category term="Servier Laboratories SA"></category></entry><entry><title>GMO corn: France rejects report by EU food agency</title><link href="http://biotechresearchinfo.com/biotechnology/gmo-corn-france-rejects-report-eu-food-agency-582082a" rel="alternate"></link><updated>2010-04-16T11:31:14Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/biotechnology/gmo-corn-france-rejects-report-eu-food-agency-582082a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt; on Friday rejected a report by the &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt;'s food safety watchdog that said a controversial strain of genetically-modified corn was safe.&lt;/p&gt;&lt;p&gt;In a joint statement, the French ecology and agriculture ministries said the &lt;a title="Italy" href="/topic/Italy" &gt;Italy&lt;/a&gt;-based &lt;a title="European Food Safety Authority" href="/topic/European+Food+Safety+Authority" &gt;European Fo...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Genetics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Nature and the Environment"></category><category term="United States"></category><category term="European Union"></category><category term="North America"></category><category term="China"></category><category term="Germany"></category><category term="Italy"></category><category term="Europe"></category><category term="Austria"></category><category term="France"></category><category term="Asia"></category><category term="South America"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="East Asia"></category><category term="Monsanto Company"></category><category term="Luxembourg"></category><category term="European Food Safety Authority"></category><category term="Southern Europe"></category></entry><entry><title>EU ministers leave open possibility of clone food</title><link href="http://biotechresearchinfo.com/cloning/eu-ministers-leave-open-possibility-clone-food-569611a" rel="alternate"></link><updated>2010-04-16T11:41:32Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/cloning/eu-ministers-leave-open-possibility-clone-food-569611a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; farm ministers revived the row over 'Frankenfoods' Monday by retaining the possibility of cloned animal products being sold in &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt;, despite scientific uncertainty and Green opposition.&lt;/p&gt;&lt;p&gt;Meeting in &lt;a title="Luxembourg" href="/topic/Luxembourg" &gt;Luxembourg&lt;/a&gt;, the agriculture ministers agreed a set of new rules for the cloned products, included in the category of "novel food...</summary><category term="Food and Cooking"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Luxembourg"></category><category term="European Food Safety Authority"></category><category term="Ethnic and Regional Cuisines"></category></entry><entry><title>New Biological Therapy Ilaris Approved In US To Treat Children And Adults With CAPS, A Serious Life-Long Auto-Inflammatory Disease</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/new-biological-therapy-ilaris-approved-treat-children-adults-caps-lifelong-autoinflammatory-disease-3010615a" rel="alternate"></link><updated>2010-10-24T09:15:04Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-24:/pharmaceuticals-sector/new-biological-therapy-ilaris-approved-treat-children-adults-caps-lifelong-autoinflammatory-disease-3010615a/</id><summary type="html">...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="North America"></category><category term="Europe"></category><category term="Australia"></category><category term="Canada"></category><category term="Food and Drug Administration"></category><category term="Switzerland"></category><category term="University of California-San Diego"></category><category term="Novartis AG"></category><category term="The New England Journal of Medicine"></category><category term="Western Europe"></category><category term="Oceania"></category><category term="Basel"></category><category term="FCAS"></category><category term="Trevor Mundel"></category><category term="American Society of Hematology"></category><category term="Ilaris"></category><category term="John Gilardi"></category><category term="Edwin Valeriano"></category><category term="Isabella Zinck"></category><category term="Jill Pozarek"></category><category term="Richard Jarvis"></category><category term="Hal Hoffman"></category><category term="L. W Durrant"></category><category term="National Horizon Scanning Centre"></category></entry><entry><title>Artificial Microlungs Grown on Chips</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/artificial-microlungs-grown-chips-3297765a" rel="alternate"></link><updated>2010-10-26T20:33:48Z</updated><author><name>Popular Science</name></author><id>tag:biotechresearchinfo.com,2010-10-26:/pharmaceuticals-sector/artificial-microlungs-grown-chips-3297765a/</id><summary type="html">...</summary><category term="Animal Cruelty"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Popular Science Magazine"></category></entry><entry><title>EU to examine Pfizer takeover of rival Wyeth</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-examine-pfizer-takeover-rival-wyeth-546674a" rel="alternate"></link><updated>2010-04-16T12:00:03Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-examine-pfizer-takeover-rival-wyeth-546674a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;'s competition services will examine US drug manufacturer &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer Inc&lt;/a&gt;'s takeover of rival Wyeth, the largest pharmaceutical takeover deal in nearly a decade, the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; announced Tuesday.&lt;/p&gt;&lt;p&gt;The EU Commission will give its opinion on July 6 on whether the deal breaches European competit...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Viagra"></category><category term="Lipitor"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Brussels"></category><category term="Warner-Lambert Corporation"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Germany bans GM maize: minister</title><link href="http://biotechresearchinfo.com/biotechnology/germany-bans-gm-maize-minister-292292a" rel="alternate"></link><updated>2010-10-22T10:22:07Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/germany-bans-gm-maize-minister-292292a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="Germany" href="/topic/Germany" &gt;Germany&lt;/a&gt; said Tuesday it was banning a type of genetically-modified maize manufactured by &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; biotech giant &lt;a title="Monsanto Company" href="/topic/Monsanto+Company" &gt;Monsanto&lt;/a&gt;, the only GM crop permitted until now in the country.&lt;/p&gt;&lt;p&gt;Agriculture &lt;a title="Ilse Aigner" href="/topic/Ilse+Aigner" &gt;Minister Ilse Aigner&lt;/a&gt; told reporters she was outlawing the cultivation of MON 810 ma...</summary><category term="Technology"></category><category term="Biotechnology"></category><category term="Crop Production"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Monsanto Company"></category><category term="Luxembourg"></category><category term="Ilse Aigner"></category><category term="Leif Miller"></category><category term="Nathalie Charbonneau"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Consumer Non-Cyclicals"></category></entry><entry><title>EU foiled in bid to force France, Greece to allow GM crop</title><link href="http://biotechresearchinfo.com/biotechnology/eu-foiled-bid-force-france-greece-gm-crop-374828a" rel="alternate"></link><updated>2010-10-22T10:12:03Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/eu-foiled-bid-force-france-greece-gm-crop-374828a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; was foiled Monday in its bid to force &lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt; and &lt;a title="Greece" href="/topic/Greece" &gt;Greece&lt;/a&gt; to allow genetically modified maize from &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; biotech giant &lt;a title="Monsanto Company" href="/topic/Monsanto+Company" &gt;Monsanto&lt;/a&gt; to be grown in their fields.&lt;/p&gt;&lt;p&gt;Food chain experts from the &lt;a...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="French Politics"></category><category term="Sciences"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Crop Production"></category><category term="United States"></category><category term="European Union"></category><category term="Germany"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Hungary"></category><category term="Brussels"></category><category term="Monsanto Company"></category><category term="Malta"></category><category term="European Food Safety Authority"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Consumer Non-Cyclicals"></category></entry><entry><title>Sanofi Aventis wins EU OK to buy Zentiva</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/sanofi-aventis-wins-eu-buy-zentiva-342942a" rel="alternate"></link><updated>2010-04-16T14:52:26Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/sanofi-aventis-wins-eu-buy-zentiva-342942a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="France" href="/topic/France" &gt;France&lt;/a&gt;'s &lt;a title="Sanofi-Aventis SA" href="/topic/Sanofi-Aventis+SA" &gt;Sanofi-Aventis SA&lt;/a&gt; must sell off medicines in eastern &lt;a title="Europe" href="/topic/Europe" &gt;Europe&lt;/a&gt; to win &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; antitrust approval to buy a Czech generic drug maker, the &lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; said Wednesday.&lt;/p&gt;&lt;p&gt;The French pharmaceutical com...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Slovakia"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Bulgaria"></category><category term="France"></category><category term="Western Europe"></category><category term="The Balkans"></category><category term="Sanofi-Aventis SA"></category><category term="Central Europe"></category><category term="Romania"></category><category term="Hungary"></category><category term="Czech Republic"></category><category term="Estonia"></category><category term="Maalox"></category><category term="Baltic Countries"></category><category term="Zentiva NV"></category></entry><entry><title>EU says drug makers blocked cheaper medicines</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-drug-makers-blocked-cheaper-medicines-396750a" rel="alternate"></link><updated>2010-04-16T14:06:09Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-drug-makers-blocked-cheaper-medicines-396750a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; says major pharmaceutical firms blocked sale of cheaper generic medicines to hike profits&lt;/div&gt;&lt;div&gt;&lt;p&gt;European patients had to pay some euro3 billion ($3.87 billion) more for medicines in 2000-2007 because pharmaceutical companies deliberately stalled the sale of cheaper generic versions, EU antitrust regulators said Friday.&lt;/p&gt;&lt;p&gt;An investigation of major pharmaceutical companies — including &lt;a title="Pfizer Inc....</summary><category term="Company Activities and Information"></category><category term="Research and Development"></category><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Neelie Kroes"></category><category term="Sandoz International GmbH"></category><category term="Losec"></category></entry><entry><title>EU says drugmakers blocked cheaper medicines</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-drugmakers-blocked-cheaper-medicines-396562a" rel="alternate"></link><updated>2010-04-16T14:06:17Z</updated><author><name>AP Features</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-drugmakers-blocked-cheaper-medicines-396562a/</id><summary type="html">&lt;div&gt;&lt;p&gt;European patients had to pay some euro3 billion ($3.87 billion) more for medicines in 2000-2007 because pharmaceutical companies deliberately stalled the sale of cheaper generic versions, &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; antitrust regulators said Friday.&lt;/p&gt;&lt;p&gt;An investigation of major pharmaceutical companies — including &lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer Inc.&lt;/a&gt;, &lt;a title="GlaxoSmithKline plc" href="/topic/GlaxoSmithKline+plc" &gt;Glaxo...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Health Care Services Sector"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="New Jersey"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="AstraZeneca Group"></category><category term="Novartis AG"></category><category term="Western Europe"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="Neelie Kroes"></category><category term="Sandoz International GmbH"></category><category term="Losec"></category></entry><entry><title>EU threatens antitrust action against drugmakers</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-threatens-antitrust-action-drugmakers-396549a" rel="alternate"></link><updated>2010-04-16T14:06:17Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/eu-threatens-antitrust-action-drugmakers-396549a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; &lt;a title="Neelie Kroes" href="/topic/Neelie+Kroes" &gt;Competition Commissioner Neelie Kroes&lt;/a&gt; threatened Friday to take antitrust action against drug companies that conspire to thwart European competition rules.&lt;/p&gt;&lt;p&gt;Unveiling preliminary findings from a sector-wide probe, she accused drug companies of blocking or delaying generic or more affordable medicines from coming to market, driving up costs for consumers and taxpayer...</summary><category term="Law"></category><category term="Antitrust Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Neelie Kroes"></category></entry><entry><title>EU panel OKs 2 genetically modified corn products</title><link href="http://biotechresearchinfo.com/biotechnology/eu-panel-oks-2-genetically-modified-corn-products-504135a" rel="alternate"></link><updated>2010-10-22T10:10:19Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-10-22:/biotechnology/eu-panel-oks-2-genetically-modified-corn-products-504135a/</id><summary type="html">&lt;div id="subtitle"&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; food safety agency panel approves 2 genetically modified corn products&lt;/div&gt;&lt;div&gt;&lt;p&gt;The European Union's food safety agency approved two genetically modified corns Friday, putting renewed pressure on EU nations to drop their objections to the use of biotech crops.&lt;/p&gt;&lt;p&gt;Scientists at the &lt;a title="Parma" href="/topic/Parma" &gt;Parma&lt;/a&gt;, &lt;a title="Italy" href="/topic/Italy" &gt;Italy&lt;/a&gt;-based &lt;a title="European Food Sa...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Food Safety"></category><category term="Crop Production"></category><category term="United States"></category><category term="European Union"></category><category term="Italy"></category><category term="Europe"></category><category term="European Commission"></category><category term="Switzerland"></category><category term="Austria"></category><category term="France"></category><category term="Western Europe"></category><category term="Poland"></category><category term="Greece"></category><category term="The Balkans"></category><category term="Central Europe"></category><category term="Parma"></category><category term="Mike Hall"></category><category term="Monsanto Company"></category><category term="Greenpeace International"></category><category term="Syngenta Corporation"></category><category term="European Food Safety Authority"></category><category term="Southern Europe"></category><category term="Pioneer Hi-Bred International Inc."></category><category term="Marta Vetier"></category><category term="Genetic Engineering"></category><category term="Genetically Modified Organisms"></category><category term="Consumer Non-Cyclicals"></category></entry><entry><title>Sanofi-Aventis withdraws anti-obesity drug from sale in Europe</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/sanofiaventis-withdraws-antiobesity-drug-sale-europe-493252a" rel="alternate"></link><updated>2010-04-16T12:45:51Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/sanofiaventis-withdraws-antiobesity-drug-sale-europe-493252a/</id><summary type="html">&lt;div&gt;&lt;p&gt;&lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; authorities suspended sales of pharmaceutical giant &lt;a title="Sanofi-Aventis SA" href="/topic/Sanofi-Aventis+SA" &gt;Sanofi-Aventis&lt;/a&gt;' anti-obesity drug &lt;a title="Acomplia" href="/topic/Acomplia" &gt;Acomplia&lt;/a&gt; across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.&lt;/p&gt;&lt;p&gt;"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed,...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Europe"></category><category term="European Medicines Agency"></category><category term="Sanofi-Aventis SA"></category><category term="Acomplia"></category></entry><entry><title>Health Highlights: Oct. 10,  2008</title><link href="http://biotechresearchinfo.com/cloning/health-highlights-oct-10-2008-2949497a" rel="alternate"></link><updated>2010-10-23T16:01:23Z</updated><author><name>Drugs.com</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/cloning/health-highlights-oct-10-2008-2949497a/</id><summary type="html">...</summary><category term="Mental Health"></category><category term="Mental Health Treatments"></category><category term="Mood Disorders"></category><category term="Depression"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="European Union"></category><category term="India"></category><category term="United Kingdom"></category><category term="Asia"></category><category term="Western Europe"></category><category term="British Broadcasting Corporation"></category><category term="Mumbai"></category><category term="Tibet"></category><category term="South Asia"></category><category term="Dalai Lama"></category><category term="New Delhi"></category><category term="Canadian Broadcasting Corporation"></category><category term="The Australian National University"></category><category term="European Food Safety Authority"></category><category term="Agence France-Presse"></category><category term="Androulla Vassiliou"></category><category term="Health Protection Agency"></category><category term="Helen Christensen"></category><category term="Klaus Linde"></category><category term="Genetic Engineering"></category><category term="Mental Health Drug Therapy"></category><category term="Antidepressants"></category><category term="Paul Corry"></category></entry><entry><title>Oct. 10,  2008</title><link href="http://biotechresearchinfo.com/cloning/oct-10-2008-2974715a" rel="alternate"></link><updated>2010-10-23T19:04:07Z</updated><author><name>EverydayHealth.com</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/cloning/oct-10-2008-2974715a/</id><summary type="html">...</summary><category term="Mental Health"></category><category term="Mental Health Treatments"></category><category term="Mood Disorders"></category><category term="Depression"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="European Union"></category><category term="India"></category><category term="United Kingdom"></category><category term="Asia"></category><category term="Western Europe"></category><category term="British Broadcasting Corporation"></category><category term="Mumbai"></category><category term="Tibet"></category><category term="South Asia"></category><category term="Dalai Lama"></category><category term="New Delhi"></category><category term="Canadian Broadcasting Corporation"></category><category term="The Australian National University"></category><category term="European Food Safety Authority"></category><category term="Agence France-Presse"></category><category term="Androulla Vassiliou"></category><category term="Health Protection Agency"></category><category term="Helen Christensen"></category><category term="Klaus Linde"></category><category term="Genetic Engineering"></category><category term="Mental Health Drug Therapy"></category><category term="Antidepressants"></category><category term="Paul Corry"></category></entry><entry><title>Europeans have little appetite for Frankenfood: survey</title><link href="http://biotechresearchinfo.com/cloning/europeans-appetite-frankenfood-survey-187495a" rel="alternate"></link><updated>2010-04-16T16:47:11Z</updated><author><name>AFP Global Edition</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/cloning/europeans-appetite-frankenfood-survey-187495a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Europeans are generally opposed to meat from cloned animals, feeling not enough is known about the long-term effects of eating it, according to an &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; survey published Thursday.&lt;/p&gt;&lt;p&gt;The Eurobarometer study showed that more than eight out of 10 EU consumers believe "we don't have enough experience about the long-term health and safety effects of using cloned animals for food" and that the long-term effects of cloning are unknown...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="European Union"></category><category term="European Parliament"></category><category term="European Food Safety Authority"></category><category term="Androulla Vassiliou"></category></entry><entry><title>Oct. 9,  2008</title><link href="http://biotechresearchinfo.com/cloning/oct-9-2008-2974732a" rel="alternate"></link><updated>2010-10-23T19:04:08Z</updated><author><name>EverydayHealth.com</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/cloning/oct-9-2008-2974732a/</id><summary type="html">...</summary><category term="Trade"></category><category term="Imports and Exports"></category><category term="Cancer"></category><category term="Colorectal Cancer"></category><category term="Ovarian Cancer"></category><category term="Health Care Issues"></category><category term="Mood Disorders"></category><category term="Depression"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food Safety"></category><category term="Health Care Services Sector"></category><category term="Medical and Diagnostic Laboratories"></category><category term="United States"></category><category term="European Union"></category><category term="The New York Times Company"></category><category term="United Press International Inc."></category><category term="New York"></category><category term="China"></category><category term="United Kingdom"></category><category term="Orlando (Florida)"></category><category term="Canada"></category><category term="Food and Drug Administration"></category><category term="Asia"></category><category term="Women's Health"></category><category term="Western Europe"></category><category term="Farmington"></category><category term="State University of New York at Stony Brook"></category><category term="Singapore"></category><category term="British Broadcasting Corporation"></category><category term="The Associated Press"></category><category term="East Asia"></category><category term="Costco Wholesale Corporation"></category><category term="University of Connecticut"></category><category term="The Canadian Press"></category><category term="Chinese Ministry of Health"></category><category term="European Food Safety Authority"></category><category term="Agence France-Presse"></category><category term="Androulla Vassiliou"></category><category term="Health Protection Agency"></category><category term="American College of Gastroenterology"></category><category term="Klaus Linde"></category><category term="Laboratory Corporation of America Holdings"></category><category term="Eric Lindblom"></category><category term="Joseph Anderson"></category><category term="Smoking and Tobacco Use"></category><category term="Canadian Dollar"></category><category term="Genetic Engineering"></category><category term="Zvi Alpern"></category></entry><entry><title>UPDATE 1-EU says Zentiva/Sanofi deal notification incomplete</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/update-1eu-zentivasanofi-deal-notification-incomplete-2306021a" rel="alternate"></link><updated>2010-10-21T09:41:59Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/pharmaceuticals-sector/update-1eu-zentivasanofi-deal-notification-incomplete-2306021a/</id><summary type="html">...</summary><category term="Company Activities and Information"></category><category term="Mergers and Acquisitions"></category><category term="Takeovers"></category><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Sanofi-Aventis SA"></category><category term="Brussels"></category><category term="Zentiva NV"></category></entry><entry><title>NHS drug bill faces EU threat</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/nhs-drug-bill-faces-eu-threat-456239a" rel="alternate"></link><updated>2010-04-16T13:18:56Z</updated><author><name>guardian.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/pharmaceuticals-sector/nhs-drug-bill-faces-eu-threat-456239a/</id><summary type="html">&lt;div&gt;&lt;p&gt;The NHS's &amp;amp;amp;amp;pound;11bn annual bill for drugs could soar if pharmaceutical companies are allowed to start pushing promotional 'information' about their products directly to patients, claim health and consumer groups.&lt;/p&gt;&lt;p&gt;The &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt; will next month unveil plans to let drug firms use the media to give information about prescription-only medicines. But opponents argue the controversial proposals would come close...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="European Commission"></category><category term="British Medical Association"></category><category term="Royal College of Physicians"></category><category term="Association of the British Pharmaceutical Industry"></category><category term="Pete Moorey"></category></entry><entry><title>GM debate: Cloned meat safe to eat says EU's food agency</title><link href="http://biotechresearchinfo.com/cloning/gm-debate-cloned-meat-safe-eat-eus-food-agency-200515a" rel="alternate"></link><updated>2010-04-16T16:36:23Z</updated><author><name>guardian.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-04-16:/cloning/gm-debate-cloned-meat-safe-eat-eus-food-agency-200515a/</id><summary type="html">&lt;div&gt;&lt;p&gt;Beef and pork produced from healthy cloned cattle and pigs are as safe as meat from conventionally bred animals, the &lt;a title="European Food Safety Authority" href="/topic/European+Food+Safety+Authority" &gt;European Food Safety Authority&lt;/a&gt; said yesterday.&lt;/p&gt;&lt;p&gt;But the &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;'s food safety agency, giving its long-awaited final scientific opinion on animal cloning, said animals carrying cloned embryos, and their offspring, had signif...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food Safety"></category><category term="European Union"></category><category term="Germany"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="Western Europe"></category><category term="Dan Collins"></category><category term="European Food Safety Authority"></category></entry><entry><title>EU food safety experts say NO to cloned meat</title><link href="http://biotechresearchinfo.com/cloning/eu-food-safety-experts-cloned-meat-2368511a" rel="alternate"></link><updated>2010-10-21T10:19:25Z</updated><author><name>ThisIsLondon.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/cloning/eu-food-safety-experts-cloned-meat-2368511a/</id><summary type="html">...</summary><category term="Endocrinology"></category><category term="Miscarriage"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Animal Cruelty"></category><category term="Food Safety"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Women's Health"></category><category term="Western Europe"></category><category term="Parliament of the United Kingdom"></category><category term="RSPCA"></category><category term="European Food Safety Authority"></category><category term="Compassion in World Farming"></category><category term="Vittorio Silano"></category><category term="Sue Davies"></category><category term="Genetic Engineering"></category><category term="Peter Stevenson"></category></entry><entry><title>EU expected to ban selling of cloned meat for food</title><link href="http://biotechresearchinfo.com/cloning/eu-expected-ban-selling-cloned-meat-food-2368189a" rel="alternate"></link><updated>2010-10-21T10:19:15Z</updated><author><name>ThisIsLondon.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/cloning/eu-expected-ban-selling-cloned-meat-food-2368189a/</id><summary type="html">...</summary><category term="Endocrinology"></category><category term="Miscarriage"></category><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Animal Cruelty"></category><category term="Food Safety"></category><category term="Social Issues"></category><category term="Animal Rights"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Europe"></category><category term="European Commission"></category><category term="Women's Health"></category><category term="Western Europe"></category><category term="Parliament of the United Kingdom"></category><category term="RSPCA"></category><category term="European Food Safety Authority"></category><category term="Compassion in World Farming"></category><category term="Vittorio Silano"></category><category term="Sue Davies"></category><category term="Genetic Engineering"></category><category term="Peter Stevenson"></category><category term="Nikki Osborne"></category></entry><entry><title>Ipsen: What It Costs To Buy Into North America</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/ipsen-costs-buy-north-america-2234433a" rel="alternate"></link><updated>2010-10-21T08:56:43Z</updated><author><name>SeekingAlpha</name></author><id>tag:biotechresearchinfo.com,2010-10-21:/pharmaceuticals-sector/ipsen-costs-buy-north-america-2234433a/</id><summary type="html">...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Western Europe"></category><category term="Vernalis plc"></category><category term="Apokyn"></category></entry><entry><title>EU widens scope of antitrust inquiry into pharmaceutical sector - report</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-widens-scope-antitrust-inquiry-pharmaceutical-sector-report-2220553a" rel="alternate"></link><updated>2010-10-19T16:35:02Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-19:/pharmaceuticals-sector/eu-widens-scope-antitrust-inquiry-pharmaceutical-sector-report-2220553a/</id><summary type="html">...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Health Care Issues"></category><category term="Prescription Drugs"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Europe"></category><category term="European Commission"></category><category term="GlaxoSmithKline plc"></category><category term="Pfizer Inc."></category><category term="Sanofi-Aventis SA"></category><category term="International Herald Tribune SAS"></category><category term="Neelie Kroes"></category></entry><entry><title>EU gives green light for cloned food to go on sale in UK shops</title><link href="http://biotechresearchinfo.com/cloning/eu-green-light-cloned-food-sale-uk-shops-2119681a" rel="alternate"></link><updated>2010-10-16T19:41:30Z</updated><author><name>ThisIsLondon.co.uk</name></author><id>tag:biotechresearchinfo.com,2010-10-16:/cloning/eu-green-light-cloned-food-sale-uk-shops-2119681a/</id><summary type="html">...</summary><category term="Sciences"></category><category term="Life Sciences"></category><category term="Biology"></category><category term="Biotechnology"></category><category term="Cloning"></category><category term="Food Safety"></category><category term="United States"></category><category term="European Union"></category><category term="United Kingdom"></category><category term="Western Europe"></category><category term="Shropshire"></category><category term="European Food Safety Authority"></category><category term="Soil Association"></category><category term="Food Standards Agency"></category><category term="Genetic Engineering"></category></entry><entry><title>EU, U.S. regulators ease process for orphan drugs</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/eu-regulators-ease-process-orphan-drugs-2894793a" rel="alternate"></link><updated>2010-10-23T02:39:15Z</updated><author><name>Environmental News Network</name></author><id>tag:biotechresearchinfo.com,2010-10-23:/pharmaceuticals-sector/eu-regulators-ease-process-orphan-drugs-2894793a/</id><summary type="html">...</summary><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Economic Policy"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="European Commission"></category><category term="Food and Drug Administration"></category><category term="European Medicines Agency"></category><category term="Financial Regulatory Policy"></category></entry><entry><title>Merck KGaA's cyanide antidote recommended by EU's CHMP expert panel</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/merck-kgaas-cyanide-antidote-recommended-eus-chmp-expert-panel-2049000a" rel="alternate"></link><updated>2010-10-15T14:58:56Z</updated><author><name>Forbes</name></author><id>tag:biotechresearchinfo.com,2010-10-15:/pharmaceuticals-sector/merck-kgaas-cyanide-antidote-recommended-eus-chmp-expert-panel-2049000a/</id><summary type="html">...</summary><category term="Sciences"></category><category term="Poisoning"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="United States"></category><category term="European Union"></category><category term="Iceland"></category><category term="Norway"></category><category term="Europe"></category><category term="Food and Drug Administration"></category><category term="European Medicines Agency"></category><category term="Geneva (Switzerland)"></category><category term="Nordic Countries"></category><category term="Liechtenstein"></category><category term="Merck Serono SA"></category><category term="Merck KGaA"></category></entry><entry><title>Another Disappointing Quarter for Omrix Biopharmaceuticals</title><link href="http://biotechresearchinfo.com/biotechnology/disappointing-quarter-omrix-biopharmaceuticals-1977442a" rel="alternate"></link><updated>2010-10-15T09:33:42Z</updated><author><name>SeekingAlpha</name></author><id>tag:biotechresearchinfo.com,2010-10-15:/biotechnology/disappointing-quarter-omrix-biopharmaceuticals-1977442a/</id><summary type="html">...</summary><category term="Marketing"></category><category term="Sales Forecasting"></category><category term="Technology"></category><category term="Biotechnology"></category><category term="European Union"></category></entry><entry><title>GlaxoSmithKline's Recent Pricing Deals</title><link href="http://biotechresearchinfo.com/pharmaceuticals-sector/glaxosmithklines-pricing-deals-1832833a" rel="alternate"></link><updated>2010-10-13T05:42:36Z</updated><author><name>SeekingAlpha</name></author><id>tag:biotechresearchinfo.com,2010-10-13:/pharmaceuticals-sector/glaxosmithklines-pricing-deals-1832833a/</id><summary type="html">...</summary><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="European Union"></category><category term="Financial Times Ltd."></category><category term="Europe"></category><category term="France"></category><category term="GlaxoSmithKline plc"></category><category term="Western Europe"></category><category term="Ben Hirschler"></category><category term="Andrew Jack"></category></entry><entry><title>Hungary Power Politics</title><link href="http://biotechresearchinfo.com/photo/hungary-power-politics-2403565p" rel="alternate"></link><updated>2010-12-29T06:30:59Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-29:/photo/hungary-power-politics-2403565p/</id><summary type="html">FILE - In this Oct. 28, 2010 file photo, &lt;a title="Viktor Orban" href="/topic/Viktor+Orban" &gt;Hungarian Prime Minister Viktor Orban&lt;/a&gt; arrives for a &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; summit in &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt;, &lt;a title="Belgium" href="/topic/Belgium" &gt;Belgium&lt;/a&gt;. &lt;a title="Hungary" href="/topic/Hungary" &gt;Hungary&lt;/a&gt;'s democratic credentials are under scrutiny as it prepares to assume the EU presidency Saturday, with some crit...</summary><category term="Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="European Union"></category><category term="Europe"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Eastern Europe"></category><category term="Central Europe"></category><category term="Budapest"></category><category term="Hungary"></category><category term="Brussels"></category><category term="Belarus"></category><category term="Viktor Orban"></category><category term="Hungarian Politics"></category></entry><entry><title>Belgium Europe Financial Crisis</title><link href="http://biotechresearchinfo.com/photo/belgium-europe-financial-crisis-2401595p" rel="alternate"></link><updated>2010-12-23T09:30:49Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-23:/photo/belgium-europe-financial-crisis-2401595p/</id><summary type="html">&lt;a title="Portugal" href="/topic/Portugal" &gt;Portugal&lt;/a&gt;'s &lt;a title="Jose Socrates" href="/topic/Jose+Socrates" &gt;Prime Minister Jose Socrates&lt;/a&gt; arrives for an &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; summit in &lt;a title="Brussels" href="/topic/Brussels" &gt;Brussels&lt;/a&gt;, Friday, Dec. 17, 2010. European Union leaders are changing the treaty that underpins the bloc to make room for a huge new rescue system for countries that get into debt trouble in the long term. But they aren...</summary><category term="Jobs and Labor"></category><category term="Labor Unions"></category><category term="Politics"></category><category term="Political Policy"></category><category term="Domestic Policy"></category><category term="Economic Policy"></category><category term="International Relations"></category><category term="Diplomacy"></category><category term="Treaties"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="European Union"></category><category term="Europe"></category><category term="Portugal"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Financial Rescue Plans"></category><category term="Jose Socrates"></category><category term="Portuguese Politics"></category></entry><entry><title>China EU</title><link href="http://biotechresearchinfo.com/photo/china-eu-2400525p" rel="alternate"></link><updated>2010-12-20T22:00:14Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-20:/photo/china-eu-2400525p/</id><summary type="html">&lt;a title="European Commission" href="/topic/European+Commission" &gt;European Commission&lt;/a&gt; Vice President in charge of competition policy, &lt;a title="Joaquin Almunia" href="/topic/Joaquin+Almunia" &gt;Joaquin Almunia&lt;/a&gt;, center, speaks at the 3rd &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt;-&lt;a title="China" href="/topic/China" &gt;China&lt;/a&gt; High-level Economic and Trade Dialogue at the Diaoyutai State Guesthouse in &lt;a title="Beijing" href="/topic/Beijing" &gt;Beijing&lt;/a&gt; on Tuesday Decem...</summary><category term="Politics"></category><category term="World Politics"></category><category term="Asia-Pacific Politics"></category><category term="Chinese Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="European Union"></category><category term="Beijing"></category><category term="China"></category><category term="European Commission"></category><category term="Asia"></category><category term="East Asia"></category><category term="Joaquin Almunia"></category></entry><entry><title>Europe Financial Crisis</title><link href="http://biotechresearchinfo.com/photo/europe-financial-crisis-2398814p" rel="alternate"></link><updated>2010-12-17T09:32:36Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-17:/photo/europe-financial-crisis-2398814p/</id><summary type="html">File -  In this May 7, 2010 file photo &lt;a title="Nicolas Sarkozy" href="/topic/Nicolas+Sarkozy" &gt;French President Nicolas Sarkozy&lt;/a&gt;, center, meets with &lt;a title="Herman Van Rompuy" href="/topic/Herman+Van+Rompuy" &gt;European Council President Herman Van Rompuy&lt;/a&gt;, left, and &lt;a title="Jose Manuel Barroso" href="/topic/Jose+Manuel+Barroso" &gt;European Commission President Jose Manuel Barroso&lt;/a&gt;, right, during an &lt;a title="European Union" href="/topic/European+Union" &gt;EU&lt;/a&gt; summit at the EU Counci...</summary><category term="Financial Markets"></category><category term="Jobs and Labor"></category><category term="Labor Unions"></category><category term="Politics"></category><category term="Local Politics"></category><category term="World Politics"></category><category term="European Politics"></category><category term="EU Politics"></category><category term="French Politics"></category><category term="European Union"></category><category term="Europe"></category><category term="Belgium"></category><category term="Western Europe"></category><category term="Brussels"></category><category term="Nicolas Sarkozy"></category><category term="Jose Manuel Barroso"></category><category term="Herman Van Rompuy"></category></entry><entry><title>Belgium EU Chocolate Rabbit</title><link href="http://biotechresearchinfo.com/photo/belgium-eu-chocolate-rabbit-2398745p" rel="alternate"></link><updated>2010-12-17T03:31:56Z</updated><author><name>AP News</name></author><id>tag:biotechresearchinfo.com,2010-12-17:/photo/belgium-eu-chocolate-rabbit-2398745p/</id><summary type="html">FILE - In this March 15, 2006 file photo, chocolate rabbits from the Swiss chocolate maker Lindt &amp; Spruengli are seen on display in Kilchberg, &lt;a title="Switzerland" href="/topic/Switzerland" &gt;Switzerland&lt;/a&gt;. As of Friday, Dec. 17, 2010, chocolate rabbits, mice and reindeer remain free to roam, unshackled by trademarks, after the &lt;a title="European Union" href="/topic/European+Union" &gt;European Union&lt;/a&gt;'s highest court ruled against chocolate producers that wanted to claim the dainty sweets as ...</summary><category term="Judiciary"></category><category term="Trials"></category><category term="Food and Cooking"></category><category term="Foods"></category><category term="Chocolate"></category><category term="Nature and the Environment"></category><category term="Wildlife"></category><category term="Mammals"></category><category term="Food and Beverage Sector"></category><category term="Food Manufacturing"></category><category term="Chocolate and Confectionery Manufacturing"></category><category term="European Union"></category><category term="Europe"></category><category term="Switzerland"></category><category term="Western Europe"></category><category term="Walter Bieri"></category><category term="Consumer Non-Cyclicals"></category></entry></feed>
